All posts by: Michael Zand

About Michael Zand

Regeneus secures commercial rights for breakthrough stem cell technology – Proactive Investors Australia

Continue reading

2015-11-24

Proactive Investors Australia

Regeneus secures commercial rights for breakthrough stem cell technology
Proactive Investors Australia
The technology developed by researchers at the Australian Research Council’s Centre of Excellence for Nanoscale BioPhotonics (CNBP) at Macquarie allows high potency secreting stem cells for the first time ever to be identified and selected for the …
Regeneus Ltd (ASX:RGS) High Potency Stem Cells for Next Generation Cell TherapiesABN Newswire (press release)

all 3 news articles »

Continue reading

2015-11-24

Mirror.co.uk

The endless miracle of stem cell therapy
Mirror.co.uk
London’s pioneering Moorfields Eye Hospital recently announced that a revolutionary procedure using stem cells has been carried out on a patient with AMD – age-related macular degeneration – a condition that affects a quarter of people aged over 60 in

Continue reading

2015-11-23

Medical Xpress

Stem cell treatment mediates immune response to spinal cord injury in pre
Medical Xpress
Scientists at Case Western Reserve University (CWRU) School of Medicine have demonstrated that a family of therapeutic stem cells called multipotent adult progenitor cells (MAPC) lessen the consequences of the immune system’s damaging second wave …

and more »